Fixing Healthcare Podcast

Fixing Healthcare Podcast

By Robert Pearl and Jeremy CorrNewsMedicineHealth & FitnessGovernmentPolitics
Download on the App Store

Fixing Healthcare Podcast episodes

  • FHC #235: Gigi Robinson on chronic illness, self-advocacy & finding hope

    Living with chronic illness can be isolating, exhausting and frustrating. Beyond the physical symptoms, patients must learn to navigate medical appointments, evaluate treatment options and explain their experiences to people who will never fully understand what they’re going through.

    Few know those challenges better than Gigi Robinson.

    A model, author, speaker and patient advocate, Robinson has lived with multiple chronic conditions, including Ehlers-Danlos syndrome, endometriosis and alpha-gal syndrome. She’s also built a public platform around helping people with chronic illness feel seen, heard and empowered.

    In this episode of Fixing Healthcare, Robinson joins Dr. Robert Pearl and Jeremy Corr for a deeply personal conversation about the challenges of chronic disease and the lessons she’s learned from navigating the American healthcare system.

    Rather than focusing on national healthcare policy or systemwide change, Robinson offers something equally valuable: a patient’s perspective on the everyday experiences that shape our nation’s health and quality of life.

    Finding your voice as a patient

    Robinson learned the importance of self-advocacy early in life, growing up with family members who worked in healthcare. She explains how describing symptoms with greater specificity can help clinicians make better decisions — and why patients shouldn’t be afraid to ask questions, challenge assumptions or seek additional opinions.

    She also discusses how social media and generative AI can help patients prepare for appointments, provided they treat information from these sources as starting points for conversations with qualified clinicians rather than substitutes for professional medical advice.

    Building a team, not searching for a miracle

    After years of working with specialists, therapists and other practitioners, Robinson has come to appreciate the value of coordinated, individualized care.

    She encourages patients to research their options, ask practitioners about relevant experience and remain active participants in treatment decisions. She also describes her interest in complementary approaches alongside conventional medicine, emphasizing the importance of discussing these options with healthcare professionals.

    Her advice is straightforward: Don’t expect one physician or treatment to solve every problem. Build relationships with professionals who understand your needs and are willing to work together.

    Finding hope while living with illness

    Perhaps the most moving part of the conversation concerns the emotional toll of chronic disease.

    Robinson recalls feeling misunderstood by friends, teachers and colleagues. She describes the difficulty of maintaining optimism when pain and illness consume so much of daily life, and the importance of resilience, compassion and mental health support.

    Her appearance in Sports Illustrated was an extension of that mission: demonstrating that people with chronic health conditions can pursue ambitious goals and lead fulfilling lives, even when own their bodies impose significant limitations.

    Robinson also discusses her children’s book, A Kids Book About Chronic Illness, and the importance of helping young people understand their conditions without allowing illness to define their identities.

    Throughout the conversation, Robinson returns to a central message: Patients need more than diagnoses and treatment plans. They need the confidence to speak up, the support of people who understand their struggles and the hope that their lives can be meaningful and fulfilling despite ongoing health challenges.

    Listen to this episode of Fixing Healthcare for Gigi Robinson’s personal story and practical insights into patient advocacy, communication and living well with chronic illness.

    Helpful links

    • “A kids book on chronic illness” (Gigi Robinson)
    • “Gigi Robinson Won’t Let Chronic Illness Stop Her—Ever” (Sports Illustrated)
    • Find Gigi on social media: TikTok, Instagram, LinkedIn
    • “ChatGPT, MD: How AI-Empowered Doctors and Patients Can Take Back Control of American Medicine” (Robert Pearl’s newest book)
    • * * *

      Fixing Healthcare is a co-production of Dr. Robert Pearl and Jeremy Corr. Subscribe to the show via Apple, Spotify, Stitcher or wherever you find podcasts. Join the conversation or suggest a guest by following the show on Twitter and LinkedIn.

      The post FHC #235: Gigi Robinson on chronic illness, self-advocacy & finding hope appeared first on Fixing Healthcare.

      42 min
    • FHC #234: The risks of moving too fast with AI & the dangers of standing still

      Artificial intelligence is advancing at an extraordinary pace, and warnings about its dangers are becoming increasingly alarming. Technology companies are reporting troubling behavior from powerful AI systems, while researchers and government officials debate how to prevent potentially catastrophic consequences.

      But Dr. Robert Pearl sees another danger: What if fear of AI prevents medicine from using the technology to save lives?

      In this episode of Diving Deep, Pearl and co-host Jeremy Corr begin by exploring the risks and opportunities of generative AI. Later in the episode, they offer another warning that healthcare leaders can no longer afford to ignore: America’s mounting economic pressures.

      The medical dangers of standing still

      Dr. Pearl begins by acknowledging the existential risks posed by increasingly powerful AI systems. Those threats demand serious safeguards, he says, but not every application carries the same level of danger.

      Consider patients recovering from surgery, living with heart failure or managing chronic diseases such as hypertension and diabetes. Doctors know that more frequent monitoring could help identify complications earlier and improve outcomes. But most physicians lack the time to review daily blood-pressure readings, evaluate surgical wounds or track subtle changes in patients’ health between office visits.

      Generative AI agents could help fill those gaps. Pearl draws on his experience leading The Permanente Medical Group, where more frequent monitoring contributed to substantial reductions in cardiovascular mortality and better control of hypertension. AI, he argues, could make comparable levels of attention more affordable and accessible nationwide.

      What the bond market is telling healthcare

      The second half of the episode shifts to another source of concern: America’s mounting debt and the rising cost of borrowing.

      Pearl explains why bond-market trends should matter to physicians, hospitals, insurers and drug manufacturers. With federal debt exceeding $40 trillion, healthcare spending continuing to rise and employers struggling with escalating premiums, the financial pressures on American medicine are becoming increasingly difficult to ignore.

      Yet healthcare organizations continue relying on familiar strategies: higher prices, tighter insurance restrictions, hospital consolidation and greater negotiating leverage.

      Pearl argues that these approaches cannot remain effective indefinitely. Instead, he challenges four major sectors of healthcare to consider fundamentally different strategies:

      • Insurers: Move beyond restricting access and embrace payment arrangements that reward better health and lower total costs.
      • Physicians: Consider greater financial accountability through value-based contracts that reward prevention and effective chronic disease management.
      • Hospitals: Shift their focus from maximizing inpatient revenue toward coordinated outpatient care that prevents avoidable hospitalizations.
      • Drug manufacturers: Explore lower prices in exchange for expanded coverage and greater prescription volume.
      • Each approach involves risk. But Pearl warns that preserving the status quo may ultimately prove more dangerous than embracing change. He closes by describing what business strategists call an inflection point: a moment when existing assumptions no longer hold and leaders must make consequential decisions before the outcome becomes obvious.

        The two discussions offer a common lesson for American healthcare. Whether confronting powerful new technology or mounting financial pressures, leaders cannot assume that avoiding change will protect them from risk. Listen to this episode of Diving Deep to explore how AI, economics and strategic decision-making could reshape the future of medicine.

        Helpful links:

        • Doctors And Patients Shouldn’t Let Fear Define The AI Debate (Forbes)
        • Bond Market Signals Unaffordability: Healthcare Needs To Listen (Forbes)
        • Monthly Musings on American Healthcare (RobertPearlMD.com)
        • * * *

          Dr. Robert Pearl is the author of ChatGPT, MD: How AI-Empowered Patients & Doctors Can Take Back Control of American Medicine.

          Fixing Healthcare is a co-production of Dr. Robert Pearl and Jeremy Corr. Subscribe to the show via Apple, Spotify or wherever you find podcasts. Join the conversation or suggest a guest by following the show on X and LinkedIn.

          The post FHC #234: The risks of moving too fast with AI & the dangers of standing still appeared first on Fixing Healthcare.

          39 min
        • MTT #112: The votes are in. Will Congress finally tackle healthcare costs?

          The midterm elections are over. But for Americans struggling to afford medical care, the biggest questions remain unanswered.

          Family health insurance premiums now average approximately $28,000 annually for employer-sponsored coverage, up 26% in five years. Workers are paying more in premiums, deductibles and out-of-pocket expenses, while millions of Americans are cutting back on basic necessities to afford the care they need.

          In this episode of Medicine: The Truth, co-hosts Dr. Robert Pearl and Jeremy Corr examine the healthcare affordability crisis that helped shape the 2026 midterm elections, and the difficult choices awaiting the newly sworn-in Congress in January.

          Dr. Pearl explores a striking contradiction in voter attitudes. Americans across party lines overwhelmingly agree that healthcare needs major reform. But they disagree sharply over government’s role, the merits of Medicare for All and how much choice they’re willing to surrender in exchange for lower costs. The challenge, Pearl explains, is that Americans want comprehensive coverage, affordable prices and freedom to choose their care.

          Delivering all three has, so far, proven impossible.

          While politicians debate solutions, the financial pressure continues. The hosts examine how rising medical expenses are affecting workers, why Americans pay far more than people in other wealthy nations despite worse outcomes, and what a recent analysis of common orthopedic procedures reveals about the value of medical interventions.

          Also in this episode:
          • The 2026 Nobel Prize in Medicine: How three scientists pioneered optogenetics, a technique that uses light to activate or inhibit neurons.
          • AI’s growing clinical impact: New research associates AI-powered hospital alerts with lower inpatient mortality, while a pilot program involving Google’s AMIE chatbot finds promising results when AI interviews patients before primary care visits.
          • America’s worsening measles outbreak: With cases and deaths rising, Pearl warns about declining vaccination rates and the risks posed to infants who depend on herd immunity.
          • More Americans losing healthcare coverage: Why millions face disappearing insurance options, rising out-of-pocket expenses and the prospect of delaying necessary treatment.
          • The soaring cost of new medicines: A new analysis finds that roughly one-quarter of recently launched drugs carry net prices exceeding $500,000, intensifying disputes over access and affordability.
          • Listen to this episode of Medicine: The Truth for the latest medical headlines, scientific advances and a closer look at the affordability challenge confronting American healthcare.

            * * *

            Dr. Robert Pearl is the author of “ChatGPT, MD: How AI-Empowered Patients & Doctors Can Take Back Control of American Medicine” about the impact of AI on the future of medicine.

            Fixing Healthcare is a co-production of Dr. Robert Pearl and Jeremy Corr. Subscribe to the show via Apple, Spotify or wherever you find podcasts. Join the conversation or suggest a guest by following the show on X and LinkedIn.

            The post MTT #112: The votes are in. Will Congress finally tackle healthcare costs? appeared first on Fixing Healthcare.

            38 min
          • FHC #233: Can physicians fix healthcare before the system breaks?

            American healthcare is approaching an economic reckoning. Or, better yet, a doomsday clock. Spending now exceeds $5.7 trillion annually, medical costs continue to climb and millions of families are struggling to afford care. Yet the people who may be best positioned to improve the system — physicians — are exhausted, overburdened and disengaged.

            In this Unfiltered episode of Fixing Healthcare, Drs. Robert Pearl and Jonathan Fisher join cohost Jeremy Corr to confront a difficult question: How can doctors lead the changes healthcare urgently needs when so many are already struggling to get through the workday?

            Dr. Pearl begins with the economic warning signs. Healthcare spending is projected to approach $9 trillion by 2034, while employers, insurers and government programs face growing financial pressure. He argues that continuing to raise prices, restrict coverage and shift costs to patients will only make matters worse.

            The solution, he believes, requires physicians to take a more active role in redesigning care. That means preventing chronic disease, reducing avoidable hospitalizations, embracing new technologies and collaborating to improve clinical outcomes at lower costs.

            Dr. Fisher agrees that medicine must change. But he questions how much more can reasonably be expected of clinicians who already lack sufficient time, resources and authority. Many physicians, he explains, are operating in survival mode. Asking them to assume leadership responsibilities without meaningful support risks accelerating the very burnout that threatens the profession.

            Their discussion explores several questions facing American medicine:

            • Why are physicians increasingly reluctant to pursue leadership roles, and what would encourage greater participation?
            • How can clinicians collaborate to reduce costs without compromising patient care or increasing workloads?
            • What can healthcare leaders learn from advances in generative AI about teamwork, persistence and solving difficult problems?
            • Where is the line between motivating physicians to embrace change and pushing already exhausted professionals too far?
            • The conversation culminates in a sobering question from co-host Jeremy Corr: What happens if healthcare costs become so unsustainable that the system begins to break down?

              Listen to this episode of Unfiltered for a candid discussion of healthcare’s economic future, the limits of physician resilience and the leadership necessary to prevent today’s problems from becoming tomorrow’s crisis.

              HELPFUL RESOURCES

              • ‘Just One Heart’ (Jonathan Fisher’s newest book)
              • ‘ChatGPT, MD’ (Robert Pearl’s newest book)
              • Monthly Musings on American Healthcare (Robert Pearl’s newsletter)
              • * * *

                Fixing Healthcare is a co-production of Dr. Robert Pearl and Jeremy Corr. Subscribe to the show via Apple Podcasts or wherever you find podcasts. Join the conversation or suggest a guest by following the show on X and LinkedIn.

                The post FHC #233: Can physicians fix healthcare before the system breaks? appeared first on Fixing Healthcare.

                51 min
              • FHC #232: Can GLP-1s & GenAI solve healthcare’s affordability crisis?

                American healthcare keeps getting more expensive. Insurers respond by restricting access, employers cut benefits and patients pay more out of pocket. Yet the underlying problem remains: chronic diseases continue to drive much of the nation’s medical spending.

                In this episode of Diving Deep, co-hosts Dr. Robert Pearl and Jeremy Corr explore two technological advances that could help break this cycle. One is already changing how millions of Americans manage their weight. The other could transform how physicians and patients manage chronic disease.

                Together, Pearl argues, GLP-1 medications and generative AI offer a new path toward better health and more affordable care.

                Two innovations, one goal: preventing costly complications

                Pearl begins with a striking figure: Americans now spend more than $5.7 trillion annually on healthcare, with chronic diseases accounting for much of the expense. Five major conditions (obesity, diabetes, cardiovascular disease, cancer and dementia) are associated with more than $1.3 trillion in annual medical costs.

                Rather than continuing to shift these expenses among insurers, employers and patients, Pearl argues that medicine should focus on preventing the complications that generate them.

                GLP-1 medications offer one way forward. By helping patients lose substantial weight, these drugs can also reduce the risk of diabetes and other obesity-related conditions. Clinical trials demonstrate benefits that extend well beyond the number on the scale.

                But prevention alone isn’t enough. Millions of Americans already live with hypertension, diabetes and heart failure. Despite effective treatments, many struggle to control their conditions because medical care still revolves around brief office visits every few months.

                Pearl explains how GenAI agents, connected to home-monitoring devices, could change that. Rather than waiting until a patient’s next appointment, AI could analyze daily blood-pressure readings, glucose levels and weight changes, identify worsening conditions and alert clinicians when treatment needs adjusting.

                The result would be more continuous care, fewer preventable complications and potentially billions in savings. Making that vision possible, however, would require lower drug prices, compatible monitoring technology and payment models that reward keeping patients healthy.

                What a troubling AI experiment reveals about medicine’s future

                The second half of the episode explores a very different development: an OpenAI experiment in which AI agents unexpectedly began working together to solve complex cybersecurity challenges.

                According to Pearl, roughly 1,200 agents established their own means of communication, exchanged more than 70,000 messages and files, and coordinated activities beyond what researchers had anticipated. Some subsequently accessed systems at Hugging Face without authorization.

                The experiment raised serious questions about how to control increasingly capable AI. But Pearl sees another implication that deserves equal attention: what if similarly coordinated agents could work on behalf of patients?

                Imagine having an entire team of AI agents continuously analyzing your medical history, medications, test results and wearable data. Working alongside clinicians, they could identify problems earlier, assist with difficult diagnoses and provide medical guidance when doctors’ offices are closed.

                Pearl describes three possibilities: a 24/7 entry point for patients seeking medical advice, personalized guidance during hospital stays and continuous monitoring for people with chronic illnesses. These applications go far beyond the administrative tasks that dominate much of today’s medical AI adoption. They would require physicians to reconsider how much clinical responsibility can be shared with technology.

                Ultimately, both discussions arrive at the same destination: America will not solve its healthcare affordability crisis by restricting care. It will do so by keeping people healthier and treating problems before they become life-threatening.

                Listen to this episode of Diving Deep to explore how GLP-1 medications, GenAI agents and new approaches to medical care could make that future possible.

                Helpful links:

                • OpenAI’s Latest Experiment Should Change How Doctors And Patients Use GenAI (Forbes)
                • How GLP-1s And GenAI Can Solve Healthcare’s Affordability Crisis (Forbes)
                • Monthly Musings on American Healthcare (RobertPearlMD.com)
                • * * *

                  Dr. Robert Pearl is the author of ChatGPT, MD: How AI-Empowered Patients & Doctors Can Take Back Control of American Medicine.

                  Fixing Healthcare is a co-production of Dr. Robert Pearl and Jeremy Corr. Subscribe to the show via Apple, Spotify or wherever you find podcasts. Join the conversation or suggest a guest by following the show on X and LinkedIn.

                  The post FHC #232: Can GLP-1s & GenAI solve healthcare’s affordability crisis? appeared first on Fixing Healthcare.

                  40 min
                • FHC #231: Dean Ornish on lifestyle medicine, loneliness and hope

                  Dean Ornish’s life was saved by meaning, connection and lifestyle change. Then he spent 50 years proving those same forces can save others.

                  In this episode of Fixing Healthcare, Dr. Robert Pearl and Jeremy Corr welcome Dr. Dean Ornish, professor of medicine at the University of California, San Francisco (UCSF), and one of the most influential figures in lifestyle medicine.

                  Across his career, Ornish has shown that comprehensive lifestyle changes can help prevent and even reverse major chronic diseases, including heart disease, prostate cancer and, most recently, early-stage Alzheimer’s disease.

                  But this conversation begins somewhere more personal.

                  Ornish describes becoming suicidally depressed at 19 and discovering, through illness, spiritual teaching and acts of service, that healing begins when people reconnect with meaning, purpose and one another. That experience shaped his life’s work and gave him a radically different view of medicine. Drugs and surgery can be lifesaving in a crisis, he says, but they often bypass the deeper causes of disease.

                  From there, the conversation moves into the science behind his approach. Ornish explains how diet, exercise, stress reduction and love and support can affect gene expression, inflammation, telomeres, loneliness, chronic disease and survival. Ideas once dismissed as “touchy-feely,” he says, are now supported by decades of peer-reviewed research.

                  Pearl and Ornish also discuss generative AI, where both see promise and limits. AI can deliver knowledge at extraordinary speed, but Ornish emphasizes that information is not the whole story. Medicine still needs presence, listening, compassion and the kind of human connection that helps people feel seen and accepted.

                  In his closing reflection, Pearl connects Ornish’s work to the future of healthcare affordability. The nation will not fix healthcare by cutting back, he says. It will improve outcomes and lower costs by keeping people healthier, preventing chronic disease complications and aligning incentives around better care.

                  Dean Ornish has spent his career showing that health is not driven by one input alone. It is multimodal: shaped by food, movement, stress, love, purpose, connection, biology and belief. This episode is a reminder that healing is not only about adding more medical interventions. Sometimes it begins by helping people stop disturbing what they already have.

                  Helpful links:

                  • Dr. Dean Ornish (website)
                  • Undo It!: How Simple Lifestyle Changes Can Reverse Most Chronic Diseases (Dean’s book)
                  • ChatGPT, MD: How AI-Empowered Patients & Doctors Can Take Back Control of American Medicine (Robert’s book)
                  • * * *

                    Fixing Healthcare is a co-production of Dr. Robert Pearl and Jeremy Corr. Subscribe to the show via Apple, Spotify or wherever you find podcasts. Join the conversation or suggest a guest by following the show on X and LinkedIn.

                    The post FHC #231: Dean Ornish on lifestyle medicine, loneliness and hope appeared first on Fixing Healthcare.

                    50 min
                  • FHC #230: Flashback to healthcare skimping and AI-powered patients

                    Fixing Healthcare is revisiting a Diving Deep episode that feels even more important today than when it first aired in November 2023.

                    At the time, ChatGPT had been available to the public for just one year. Generative AI was still widely viewed as a fascinating but unreliable tool, impressive in some settings and error-prone in others. Many clinicians saw it as a novelty. Some saw it as a threat. Few fully grasped how quickly the technology would advance or how profoundly it might reshape the relationship between doctors and patients.

                    Nearly three years later, that early vision already feels outdated. We’ve already surpassed the vision of generative AI helping patients prepare for office visits and ask better questions. The next generation of AI agents are proving capable of helping provide care between visits: monitoring chronic disease, identifying early signs of heart failure, flagging postoperative wound infections, answering medication questions and alerting doctors when a patient’s condition begins to worsen. Instead of centering care almost entirely around the doctor’s office, these tools could extend medical expertise into the home, 24/7.

                    When the episode was released, many people worried that generative AI was not powerful enough to solve clinical problems. Now, some worry that it has become too powerful and may pose existential risks. Across the nation, health systems, technology companies and policymakers are debating how far these tools should go, how quickly they should be adopted and who should guide their use.

                    That makes this replay especially timely. In this episode, co-hosts Dr. Robert Pearl and Jeremy Corr return to two connected problems: the high cost of American healthcare and the potential for generative AI to give patients more knowledge, agency and control.

                    The first half of the conversation focuses on “skimping,” a term Pearl uses for the many ways healthcare organizations constrain costs by giving patients less care, less access or fewer resources while still charging more. He compares it to buying a box of cereal at the same price, only to discover there are fewer flakes inside. In healthcare, however, the consequences are far more serious.

                    The second half of the episode turns to generative AI and the future of the doctor-patient relationship. Pearl argues that, when used correctly, generative AI could make medicine more collaborative. Instead of relying entirely on brief office visits, patients could use AI to better understand their conditions, evaluate treatment options, track symptoms and participate more actively in decisions. Doctors, meanwhile, could benefit from patients arriving better informed and more prepared.

                    That idea was provocative in 2023. Today, it is becoming increasingly practical. Generative AI systems have grown more capable, more conversational and more widely used. The tools available now are far beyond what existed when this episode first aired.

                    And as Pearl has argued in his book ChatGPT, MD, the exponential growth of AI means that capabilities can double quickly. If a technology doubles in power each year, then after five years it is not five times stronger. It is 32 times stronger.

                    That mathematical reality gives this episode its new relevance. The conversation is both a look back at early optimism about generative AI in medicine and a reminder that even bold predictions can prove conservative when a technology advances exponentially.

                    Listen again to this early Diving Deep conversation and consider how much has changed since November 2023—and how much more may change in the next two years.

                    HELPFUL LINKS

                    • How America Skimps On Healthcare (Forbes)
                    • How Generative AI Will Upend The Doctor-Patient Relationship (Forbes)
                    • Monthly Musings on American Healthcare (Robert Pearl’s newsletter)
                    • * * *

                      Dr. Robert Pearl is the author of ChatGPT, MD: How AI-Empowered Patients & Doctors Can Take Back Control of American Medicine.

                      Fixing Healthcare is a co-production of Dr. Robert Pearl and Jeremy Corr. Subscribe to the show via Apple, Spotify or wherever you find podcasts. Join the conversation or suggest a guest by following the show on X and LinkedIn.

                      The post FHC #230: Flashback to healthcare skimping and AI-powered patients appeared first on Fixing Healthcare.

                      37 min
                    • MTT #111: Why are patients paying more before they get care?

                      In this week’s episode of Medicine: The Truth, hosts Jeremy Corr and Dr. Robert Pearl dig for the facts beneath healthcare’s biggest headlines. Today’s show opens with a problem more Americans are facing every year: rising out-of-pocket costs and the growing demand that patients pay before they receive care.

                      Pearl explains that the listener’s concern is increasingly the rule, not the exception. Total health costs per employee now average more than $20,000 a year, including premiums and out-of-pocket obligations. With projections for next year showing costs rising another 9% to 11%, workers are likely to shoulder an even greater financial burden.

                      But higher deductibles are only part of the problem. Doctors and hospitals are increasingly asking patients to pay out-of-pocket costs in advance before scheduling non-emergency procedures. Pearl says 92% of U.S. healthcare providers now either strongly encourage or require advance payment, up from 81% a year earlier. That means a patient who needs a hernia repair, gallbladder surgery, ACL repair or other painful but non-emergency procedure may be asked to pay thousands of dollars before care can proceed.

                      For Pearl, this is a warning sign of a larger affordability crisis. As premiums, deductibles, drug prices and hospital charges rise, medical costs are increasingly being treated like a hot potato, passed from the federal government to states, from insurers to employers and from employers to workers.

                      Here are the other major storylines from episode 111:

                      • President Trump has nominated Dr. Heidi Overton to lead the FDA following Marty Makary’s departure. Her support for scaling back childhood vaccine recommendations has already drawn concern from Senate Health Committee chair Dr. Bill Cassidy.
                      • The battle between politics and science is expanding. Pearl points to HHS hiring an Army doctor to investigate unsupported claims that thousands of U.S. service members died after receiving COVID vaccines, despite Pentagon reports finding no vaccine-related deaths.
                      • Personalized mRNA cancer vaccines remain one of the most exciting areas in oncology. Early Moderna and Merck data in melanoma are promising, though the full results have not yet been published.
                      • A new FDA-approved drug for advanced pancreatic cancer has generated enthusiasm because it extended life in patients who had already failed chemotherapy. But the drug is expected to cost about $480,000 a year.
                      • The Lone Star tick is spreading beyond the Southeast into New England and the upper Midwest. Unlike the deer tick associated with Lyme disease, the Lone Star tick can trigger a potentially dangerous allergic reaction to red meat.
                      • Measles cases are rising at a record-setting pace in 2026, with preventable deaths occurring among unvaccinated individuals. Falling immunization rates put the United States at risk of losing its measles elimination status.
                      • Employers are bracing for the largest healthcare cost increase in two decades. Some are responding by dropping GLP-1 coverage, limiting spousal coverage or shifting more costs to workers.
                      • New evidence from Amsterdam supports the value of long-term primary care relationships. Patients who saw the same clinician for 15 to 20 years had lower odds of emergency hospital admission, and cost reductions appeared strongest among those with relationships lasting 10 to 15 years.
                      • In a comparison of tirzepatide and semaglutide for weight loss, Pearl says tirzepatide produced greater weight loss and slightly better A1c reduction, while semaglutide had fewer reported side effects. He emphasizes that both drugs are highly effective and that cost is often the main reason patients stop taking them.
                      • The episode closes with Pearl’s provocative thoughts on generative AI. He says the time has come for healthcare professionals to stop denying its clinical power.

                        Pearl acknowledges the existential risks associated with advanced AI, but says the same capabilities also create enormous opportunities to improve outcomes, save lives and make care more accessible and affordable. American medicine, he argues, is not performing well enough to defend the status quo. Misdiagnoses, preventable medical errors and poor chronic disease control continue to kill hundreds of thousands of Americans each year.

                        Meanwhile, patients are already turning to ChatGPT, Claude, Gemini and other large language models when they have symptoms or medical questions, especially when doctors’ offices are closed or appointments are days or weeks away. Pearl says the question is no longer whether generative AI will provide clinical expertise to patients. As both a physician and a patient, he hopes healthcare professionals seize the opportunity before someone else does.

                        Tune in to hear the full discussion and subscribe to Medicine: The Truth for more fact-based analysis of the medical, scientific and policy stories shaping American healthcare.

                        * * *

                        Dr. Robert Pearl is the author of “ChatGPT, MD: How AI-Empowered Patients & Doctors Can Take Back Control of American Medicine” about the impact of AI on the future of medicine.

                        Fixing Healthcare is a co-production of Dr. Robert Pearl and Jeremy Corr. Subscribe to the show via Apple, Spotify or wherever you find podcasts. Join the conversation or suggest a guest by following the show on X and LinkedIn.

                        The post MTT #111: Why are patients paying more before they get care? appeared first on Fixing Healthcare.

                        39 min
                      • FHC #229: Revisiting Mark Cuban’s prescription for lowering healthcare costs

                        With healthcare costs projected to rise sharply next year, Fixing Healthcare with cohosts Dr. Robert Pearl and Jeremy Corr revisits one of the most popular conversations of the year: an interview with Mark Cuban, entrepreneur, longtime Shark Tank investor, former owner of the Dallas Mavericks and founder of Cost-Plus Drugs.

                        Cuban has built his healthcare work around a deceptively simple idea: patients, employers and clinicians should be able to see what things actually cost.

                        That should not be radical. But in American healthcare, transparency can feel disruptive because so much of the system depends on complexity, opacity and hidden incentives.

                        In this rerun episode, co-hosts Dr. Robert Pearl and Jeremy Corr return to Cuban’s blunt diagnosis of what is broken in healthcare. His argument begins with prescription drugs, where pharmacy benefit managers, rebates, spread pricing and opaque contracts often leave patients paying far more than they should. But the conversation quickly expands beyond medications to the broader dysfunction of American medicine.

                        Cuban’s approach to drug pricing is straightforward. Through Cost Plus Drugs, the company shows patients the actual cost of a medication, adds a flat markup and eliminates many of the middlemen who benefit when prices are hidden. The result is a model built not on secrecy, but on visibility.

                        That philosophy matters even more now, as patients and employers brace for rising healthcare costs. For many Americans, affordability is no longer an abstract policy concern. It determines whether they fill a prescription, schedule a visit, delay treatment or avoid care entirely.

                        Cuban’s critique is that the system is not merely complicated. In many ways, it is designed to be complicated. Patients struggle to understand what they owe.

                        Employers often do not know whether they are receiving the rebates they were promised. Doctors waste time fighting prior authorization, billing complexity and administrative rules that make care slower and more frustrating. Meanwhile, the organizations that benefit from opacity have little incentive to simplify anything.

                        The episode highlights several of Cuban’s core arguments:

                        • Drug prices are often detached from manufacturing costs, clinical value and common sense.
                        • Patients in deductible phases, especially those with ACA plans, can bear the full financial burden while rebates and savings flow elsewhere.
                        • Employers often assume their pharmacy benefit contracts protect them, when the details may tell a different story.
                        • Complexity protects incumbents by making it difficult for patients, clinicians and purchasers to see who benefits from the current system.
                        • Transparency gives patients and employers leverage by exposing prices, incentives and financial arrangements that otherwise remain hidden.
                        • What makes Cuban’s perspective powerful is that he comes to healthcare as an outsider. He is not defending legacy structures, professional norms or institutional habits. He asks a simpler question: if the system were designed around patients, would it look anything like this? For Cuban, the answer is no.

                          That is why this conversation remains timely. As healthcare costs continue to rise, marginal reforms and better messaging are not enough. Patients need affordability. Employers need visibility. Clinicians need less administrative friction. And the system needs incentives that are easier to understand and harder to hide.

                          Cuban’s message is that healthcare does not need more opacity, more jargon or more excuses. It needs sunlight. Listen again to this conversation with Mark Cuban and decide for yourself: if transparency can lower drug costs, what else in healthcare could it change?

                          Helpful links:

                          • Original Mark Cuban episode
                          • Mark Cuban Cost Plus Drug Company
                          • ChatGPT, MD: How AI-Empowered Patients & Doctors Can Take Back Control of American Medicine
                          • * * *

                            Fixing Healthcare is a co-production of Dr. Robert Pearl and Jeremy Corr. Subscribe to the show via Apple, Spotify or wherever you find podcasts. Join the conversation or suggest a guest by following the show on X and LinkedIn.

                            The post FHC #229: Revisiting Mark Cuban’s prescription for lowering healthcare costs appeared first on Fixing Healthcare.

                            54 min
                          • Revisiting Vinod Khosla’s vision for AI-powered healthcare

                            With all the turmoil surrounding healthcare and artificial intelligence, the Fixing Healthcare team is revisiting one of its most provocative conversations: an interview with entrepreneur, investor and technology visionary Vinod Khosla.

                            When Khosla appeared on the show in November 2024, he made a claim that drew immediate criticism from many in medicine: “The most expensive part of the healthcare system is expertise. And expertise can be tamed with AI.”

                            At the time, many listeners and social media commenters saw the statement as overly optimistic, even dismissive of the complexity of clinical care. Today, it sounds less like provocation and more like a prediction medicine is still struggling to absorb.

                            In this rerun episode, co-hosts Dr. Robert Pearl and Jeremy Corr invite listeners to hear Khosla’s remarks again in light of today’s rapidly changing AI landscape. He does not argue that technology should replace the human elements of medicine. Rather, he argues that AI can expand access to expertise, reduce the cost of routine clinical knowledge and make high-quality guidance available to more people in more places. For rural communities, patients with chronic disease and individuals waiting weeks or months for care, that possibility remains deeply consequential.

                            The episode also asks a larger question: What happens if healthcare moves too slowly? Listen again to this timely conversation with Vinod Khosla, and decide for yourself: Was he too optimistic about AI in medicine, or too cautious?

                            Helpful links:

                            • Vinod Khosla: How venture-backed tech is transforming U.S. healthcare (FHC #153)
                            • ChatGPT, MD: How AI-Empowered Patients & Doctors Can Take Back Control of American Medicine (Pearl’s newest book)
                            • Khosla Ventures (Official Site)
                            • * * *

                              Fixing Healthcare is a co-production of Dr. Robert Pearl and Jeremy Corr. Subscribe to the show via Apple, Spotify, Stitcher or wherever you find podcasts. Join the conversation or suggest a guest by following the show on Twitter and LinkedIn.

                              The post Revisiting Vinod Khosla’s vision for AI-powered healthcare appeared first on Fixing Healthcare.

                              52 min

                            About Fixing Healthcare Podcast

                            From the publisher's feed

                            “A podcast with a plan to fix healthcare” featuring Dr. Robert Pearl, Jeremy Corr and Guests